Get started
Mural Oncology plcMural Oncology plcMural Oncology plc

Mural Oncology plc

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

MURA chart


Full chart

MURA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪46.52 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−7.58 USD
Net income (FY)
‪−128.51 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪15.34 M‬
Beta (1Y)
0.85

Employees


Employees (FY)
116
Change (1Y)
−1 −0.85%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.11 M‬ USD

About Mural Oncology plc


Sector
Health Technology
Industry
Biotechnology
CEO
Caroline J. Loew
Website
muraloncology.com
Headquarters
Dublin
Founded
2017
ISIN
IE000LK2BOB4
FIGI
BBG01BCJBZ81
Mural Oncology Plc is a clinical-stage oncology company, which engages in the business of discovering and developing immunotherapies for patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MURA news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as MURA.

Frequently Asked Questions


The current price of MURA is 2.70 USD — it has increased by 11.57% in the past 24 hours. Watch Mural Oncology plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mural Oncology plc stocks are traded under the ticker MURA.
MURA stock has risen by 145.45% compared to the previous week, the month change is a −32.67% fall, over the last year Mural Oncology plc has showed a −30.23% decrease.
We've gathered analysts' opinions on Mural Oncology plc future price: according to them, MURA price has a max estimate of 16.00 USD and a min estimate of 4.00 USD. Watch MURA chart and read a more detailed Mural Oncology plc stock forecast: see what analysts think of Mural Oncology plc and suggest that you do with its stocks.
MURA reached its all-time high on Nov 16, 2023 with the price of 17.00 USD, and its all-time low was 0.95 USD and was reached on Apr 9, 2025. View more price dynamics on MURA chart.
See other stocks reaching their highest and lowest prices.
MURA stock is 14.81% volatile and has beta coefficient of 0.85. Track Mural Oncology plc stock price on the chart and check out the list of the most volatile stocks — is Mural Oncology plc there?
Today Mural Oncology plc has the market capitalization of ‪46.52 M‬, it has increased by 115.18% over the last week.
Yes, you can track Mural Oncology plc financials in yearly and quarterly reports right on TradingView.
Mural Oncology plc is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
MURA earnings for the last quarter are −2.01 USD per share, whereas the estimation was −1.99 USD resulting in a −1.11% surprise. The estimated earnings for the next quarter are −2.04 USD per share. See more details about Mural Oncology plc earnings.
Mural Oncology plc revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MURA net income for the last quarter is ‪−34.27 M‬ USD, while the quarter before that showed ‪−31.76 M‬ USD of net income which accounts for −7.92% change. Track more Mural Oncology plc financial stats to get the full picture.
No, MURA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 19, 2025, the company has 116 employees. See our rating of the largest employees — is Mural Oncology plc on this list?
Like other stocks, MURA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mural Oncology plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mural Oncology plc technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mural Oncology plc stock shows the neutral signal. See more of Mural Oncology plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.